223 related articles for article (PubMed ID: 25735984)
1. Cross talk between Leishmania donovani CpG DNA and Toll-like receptor 9: an immunoinformatics approach.
Gupta CL; Akhtar S; Waye A; Pandey NR; Pathak N; Bajpai P
Biochem Biophys Res Commun; 2015 Apr; 459(3):424-9. PubMed ID: 25735984
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 9 interaction with CpG ODN--an in silico analysis approach.
Zhou W; Li Y; Pan X; Gao Y; Li B; Qiu Z; Liang L; Zhou H; Yue J
Theor Biol Med Model; 2013 Mar; 10():18. PubMed ID: 23497207
[TBL] [Abstract][Full Text] [Related]
3. Leishmanial CpG DNA nanovesicles: A propitious prophylactic approach against visceral leishmaniasis.
Tiwari RK; Chandrakar P; Gupta CL; Sayyed U; Shekh R; Bajpai P
Int Immunopharmacol; 2021 Jan; 90():107181. PubMed ID: 33249044
[TBL] [Abstract][Full Text] [Related]
4. Unmethylated CpG motifs in the L. donovani DNA regulate TLR9-dependent delay of programmed cell death in macrophages.
Das S; Ghosh AK; Singh S; Saha B; Ganguly A; Das P
J Leukoc Biol; 2015 Feb; 97(2):363-78. PubMed ID: 25473100
[TBL] [Abstract][Full Text] [Related]
5. Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9.
Fehér K
Curr Protein Pept Sci; 2019; 20(11):1060-1068. PubMed ID: 31470785
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
7. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9.
Keestra AM; de Zoete MR; Bouwman LI; van Putten JP
J Immunol; 2010 Jul; 185(1):460-7. PubMed ID: 20498358
[TBL] [Abstract][Full Text] [Related]
8. Impelling TLR9: Road to perspective vaccine for visceral leishmaniasis.
Tiwari RK; Gupta CL; Bajpai P
Drug Dev Res; 2022 Apr; 83(2):222-224. PubMed ID: 32216115
[TBL] [Abstract][Full Text] [Related]
9. Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
Latz E; Verma A; Visintin A; Gong M; Sirois CM; Klein DC; Monks BG; McKnight CJ; Lamphier MS; Duprex WP; Espevik T; Golenbock DT
Nat Immunol; 2007 Jul; 8(7):772-9. PubMed ID: 17572678
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
[TBL] [Abstract][Full Text] [Related]
11. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.
Griebel PJ; Brownlie R; Manuja A; Nichani A; Mookherjee N; Popowych Y; Mutwiri G; Hecker R; Babiuk LA
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):11-6. PubMed ID: 16098606
[TBL] [Abstract][Full Text] [Related]
12. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation.
Peter ME; Kubarenko AV; Weber AN; Dalpke AH
J Immunol; 2009 Jun; 182(12):7690-7. PubMed ID: 19494293
[TBL] [Abstract][Full Text] [Related]
13. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
14. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
[TBL] [Abstract][Full Text] [Related]
15. TLR9 agonist CpG ODN 2395 promotes the immune response against Leishmania donovani in obesity and undernutrition mice.
He J; Huang F; Liao X; Zhang J; Wei S; Xiao Y; Zheng X; Zhu Z; Chen D; Chen J
Acta Trop; 2023 Jun; 242():106921. PubMed ID: 37030488
[TBL] [Abstract][Full Text] [Related]
16. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
Suwarti S; Yamazaki T; Svetlana C; Hanagata N
Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
[TBL] [Abstract][Full Text] [Related]
17. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 9 mediates CpG-DNA signaling.
Chuang TH; Lee J; Kline L; Mathison JC; Ulevitch RJ
J Leukoc Biol; 2002 Mar; 71(3):538-44. PubMed ID: 11867692
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9.
Ohto U; Shibata T; Tanji H; Ishida H; Krayukhina E; Uchiyama S; Miyake K; Shimizu T
Nature; 2015 Apr; 520(7549):702-5. PubMed ID: 25686612
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for species-specific activation of mouse Toll-like receptor 9.
Ishida H; Ohto U; Shibata T; Miyake K; Shimizu T
FEBS Lett; 2018 Aug; 592(15):2636-2646. PubMed ID: 29961984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
